CamDiab

CamDiab is a diabetes technology company focused on helping people with type 1 diabetes and their families manage daily life. Its main product, CamAPS FX, is an adaptive hybrid closed-loop mobile app that works with an insulin pump and continuous glucose monitor (CGM). Using sensor glucose readings, the app automatically adjusts insulin delivery and learns from an individual’s insulin needs, while allowing users to change settings. It is approved for people aged one year and older and is available for use during pregnancy. The app runs on compatible Android and iOS smartphones.

Developed at the University of Cambridge, CamAPS FX has been evaluated in randomised clinical trials. The company reports that these trials found improvements in time spent within target glucose ranges, HbA1c, hypoglycaemia, hyperglycaemia and well-being. CamDiab also provides user and healthcare professional training, support, frequently asked questions, and information about its products, safety and research. Through user stories and educational resources, the company shares experiences of living with diabetes and using its technology.